<DOC>
	<DOC>NCT00152412</DOC>
	<brief_summary>4 week open study to evaluate the safety of levocetirizine in young children (2 - 6 years) suffering from allergic rhinitis. As secondary objective, this study will assess the efficacy of the treatment by means of the T4SS (Total 4 symptoms scores of allergic rhinitis) and each of the 4 individual rhinitis symptom scores</brief_summary>
	<brief_title>Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>At Visit 1: Male or female outpatients aged 2 to 6 years old. Subjects suffering from allergic rhinitis (perennial and/or seasonal) and symptomatic as attested by the Daily Record Card (DRC). At Visit 2: Respected washout periods for the forbidden medication. â€¢ Presence of asthma requiring treatment by inhaled corticosteroids. Atopic dermatitis or urticaria requiring antihistamine treatment or the administration of oral or topical corticosteroids, or any other disease requiring the administration of oral or topical corticosteroids, immunomodulatory drugs, antiinflammatory, or cytotoxic drugs. Use during the course of the study, or during the specific washout periods, of any of the following medications: intranasal or systemic corticosteroids (within 7 days), ketotifen (within 7 days), nedocromil or cromoglicate (within 7 days), loratadine and desloratadine (within 7 days), other antihistamines (within 3 days) or decongestants (per os, nasal spray, or drops within 3 days), or any other concomitant medications that, in the opinion of the Investigator, interfered with the study. Initiation or change of dose of an immunotherapy regimen during the course of the study.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Allergic Rhinitis, safety, levocetirizine, children</keyword>
	<keyword>Xyzal</keyword>
</DOC>